This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Kracie Pharma, Ltd., National Cancer Center, The University of Toyama. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takaoka, JP (2017)
- Toyama, JP (2015 - 2018)
Company Filing History:
4 out of 5 
4 out of 263 
4 out of 38 
Years Active: 2015-2018
Title: The Innovative Contributions of Toshiki Okubo
Introduction: Toshiki Okubo is a prominent inventor based in Toyama, Japan, known for his significant contributions in the field of cancer treatment. With a total of four patents to his name, Okubo's work showcases a commitment to advancing medical science, particularly through the development of novel anticancer agents.
Latest Patents: Among Toshiki Okubo's latest patents, two innovative anticancer agents stand out. The first patent focuses on an anticancer agent designed to enhance antitumor efficacy while alleviating side effects associated with conventional treatments. This invention combines arctigenin with another anticancer component, resulting in a combination drug or kit formulation. It demonstrates the potential to inhibit tumor growth effectively while reducing cancer stem cells, ultimately extending survival rates.
The second patent offers a new approach to cancer treatment through an agent derived from burdock fruit extract. After administering a dose of arctigenin of 100 mg or more per day to a patient with pancreas cancer, significant tumor reduction and a decrease in tumor markers were observed. This anticancer agent, which contains both arctigenin and arctiin at a specific weight ratio, represents a promising advancement in cancer therapeutics.
Career Highlights: Toshiki Okubo has built a successful career working at esteemed institutions such as The University of Toyama and Kracie Pharma, Ltd. His research and innovative spirit have played a crucial role in the development of effective cancer treatments.
Collaborations: Throughout his career, Okubo has collaborated with several esteemed professionals, including Satoshi Yomoda and Hiroyasu Esumi. These collaborations have facilitated knowledge exchange and the cross-pollination of ideas, significantly impacting his inventions.
Conclusion: Toshiki Okubo's dedication to cancer research and development is evident through his innovative patents. By focusing on combining effective components to enhance treatment efficacy and reduce side effects, Okubo has made meaningful strides in the field of oncology. His work not only signifies a commitment to scientific innovation but also offers hope for those affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile